{"name":"Leucine","slug":"leucine","kind":"substance","abbreviations":["Leu"],"systematic":null,"aliases":["(S)-2-Amino-4-methylpentanoic acid","(S)-Leucine","(S)-(+)-Leucine","Leucin","(S)-2-Amino-4-methylvaleric acid","L-α-Aminoisocaproic acid","Leucine, l-","Leucinum","Leucina","FEMA No. 3297"],"brands":[],"scraped":true,"has_structure":true,"cid":6106,"classes":[],"families":[{"name":"amino acid","href":"/substituted/amino_acid"}],"physical":[{"label":"Molecular mass","value":"131.17 g/mol","copyable":false},{"label":"Appearance","value":"White glistening hexagonal plates from aqueous alcohol","copyable":false},{"label":"Density","value":"1.293 g/cu cm at 18 °C","copyable":false},{"label":"Melting point","value":"293 °C","copyable":false},{"label":"Boiling point","value":"Sublimes at 145-148 °C. Decomposes at 293-295 °C (rapid heating, sealed tube)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitric oxide/.","copyable":false},{"label":"Solubility","value":"21500 mg/L (at 25 °C)","copyable":false},{"label":"Predicted LogP","value":"-1.5","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>6</sub>H<sub>13</sub>NO<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"(2S)-2-amino-4-methylpentanoic acid","copyable":true},{"label":"SMILES","value":"CC(C)C[C@@H](C(=O)O)N","copyable":true},{"label":"InChI","value":"InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1","copyable":true},{"label":"InChIKey","value":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","copyable":true},{"label":"CAS number","value":"61-90-5","copyable":true},{"label":"UNII","value":"GMW67QNF9C","copyable":true},{"label":"PubChem CID","value":"6106","copyable":true}],"pharmacokinetics":[],"toxicity":[{"kind":"LD50","organisms":[["Rat",[{"kind":"LD50","organism":"Rat","route":"ip","dose":"5379 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Leucine hydrochloride","name":"hydrochloride","slug":"leucine_hydrochloride","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"This group of essential amino acids are identified as the branched-chain amino acids, BCAAs. Because this arrangement of carbon atoms cannot be made by humans, these amino acids are an essential element in the diet. The catabolism of all three compounds initiates in muscle and yields NADH and FADH2 which can be utilized for ATP generation. The catabolism of all three of these amino acids uses the same enzymes in the first two steps. The first step in each case is a transamination using a single BCAA aminotransferase, with a-ketoglutarate as amine acceptor. As a result, three different a-keto acids are produced and are oxidized using a common branched-chain a-keto acid dehydrogenase, yielding the three different CoA derivatives. Subsequently the metabolic pathways diverge, producing many intermediates. The principal product from valine is propionylCoA, the glucogenic precursor of succinyl-CoA. Isoleucine catabolism terminates with production of acetylCoA and propionylCoA; thus isoleucine is both glucogenic and ketogenic. Leucine gives rise to acetylCoA and acetoacetylCoA, and is thus classified as strictly ketogenic. There are a number of genetic diseases associated with faulty catabolism of the BCAAs. The most common defect is in the branched-chain a-keto acid dehydrogenase. Since there is only one dehydrogenase enzyme for all three amino acids, all three a-keto acids accumulate and are excreted in the urine. The disease is known as Maple syrup urine disease because of the characteristic odor of the urine in afflicted individuals. Mental retardation in these cases is extensive. Unfortunately, since these are essential amino acids, they cannot be heavily restricted in the diet; ultimately, the life of afflicted individuals is short and development is abnormal The main neurological problems are due to poor formation of myelin in the CNS.","side_effects":null,"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[],"members":[],"part_of":[],"links":[{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/6106"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00149"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL291962"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A15603"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=61-90-5"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0000687"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C00123"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9023203"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Leucine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/GMW67QNF9C"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 6106, Leucine. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/6106>https://pubchem.ncbi.nlm.nih.gov/compound/6106</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Leucine. UNII: GMW67QNF9C. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GMW67QNF9C>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GMW67QNF9C</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 07:05:29","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 07:05:25","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 07:05:25","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 07:05:26","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 07:05:25","note":"hmdb.ca refused automated access to HMDB0000687"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 07:05:27","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 07:05:24","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 07:05:25","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 07:05:25","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 07:05:25","note":null},{"source":"wikipedia","status":"missing","fetched_at":"2026-11-20 07:05:25","note":"no Wikipedia article with a drug infobox"}],"description":"Leucine is a  substance."}